On Friday, the U.S. Food and Drug Administration approved Eli Lilly's eczema drug for use in adults and children 12 and older. The medication is an injectable branded Ebglyss and will be available ...

When a new eczema drug called Dupixent finally became available to Sawyer a few years ago, his turnaround was fast and dramatic. Within a week, his itchiness and redness started calming down.

Apogee Therapeutics’ anti-IL-13 antibody has been tied to a 71% reduction in eczema severity after 16 weeks, hitting the main ...

A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch relief and clear skin for many patients in a clinical trial, without the ...

Eli Lilly drug Ebglyss is now FDA-approved for atopic dermatitis, an inflammatory skin disorder also known as eczema. The biologic drug came from Lilly’s $1.1 billion acquisition of Dermira in 2020.

Another new cream, Zoryve (roflumilast) is approved for mild to moderate eczema for ages 6 years and older. Zoryve is also a steroid free cream which helps to calm the eczema. What are biologics?

Eczema (Atopic Dermatitis) Treatment Written by WebMD Editorial Contributor , Felicia Wilson Medically Reviewed by Brunilda Nazario, MD on February 18, 2025 ...

Click to jump to specific eczema treatment, as recommended by our dermatologists: Best Eczema Creams; ... Oh, and Dr. Libby labels it her “new favorite petrolatum ointment,” too. AMAZON. TARGET.

A new study of adults 60 and older has found a link between starting blood pressure medication for hypertension and an increased risk of developing eczema, a condition characterized by dry, itchy ...

Living with eczema affects more than just the skin – it influences everything from sleep patterns to clothing choices and social interactions. This inflammatory skin condition, which comes from ...

A new class of medications referred to as JAK inhibitors can help change patient’s lives by reducing inflammation and itch. Many patients experience quick relief and are thrilled they don’t ...